The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain

Neziha Erken,1 Fatma Sena Dost Gunay,1 Pinar Soysal,2 Ahmet Turan Isik1 1Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; 2Department of Geriatric Medicine, Bezmialem Vakif University, Faculty of Medicine, Istanbul, TurkeyCorrespondence: Ahmet Turan IsikU...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Erken N, Dost Gunay FS, Soysal P, Isik AT
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/7a561dbbf3874fcdae405a541aac8ffa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a561dbbf3874fcdae405a541aac8ffa
record_format dspace
spelling oai:doaj.org-article:7a561dbbf3874fcdae405a541aac8ffa2021-12-02T08:51:32ZThe Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain1178-1998https://doaj.org/article/7a561dbbf3874fcdae405a541aac8ffa2020-05-01T00:00:00Zhttps://www.dovepress.com/the-effect-of-theracurmin-on-cognitive-function-in-an-older-patient-wi-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Neziha Erken,1 Fatma Sena Dost Gunay,1 Pinar Soysal,2 Ahmet Turan Isik1 1Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; 2Department of Geriatric Medicine, Bezmialem Vakif University, Faculty of Medicine, Istanbul, TurkeyCorrespondence: Ahmet Turan IsikUnit for Brain Aging and Dementia, Department of Geriatric Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey Tel +90 232 412 43 41Fax +90 232 412 43 49Email atisik@yahoo.comAbstract: Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.Keywords: chemobrain, Theracurmin, elderly, cognitive impairment, cancerErken NDost Gunay FSSoysal PIsik ATDove Medical Pressarticlechemobraintheracurminelderlycognitive impairmentcancerGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 15, Pp 691-693 (2020)
institution DOAJ
collection DOAJ
language EN
topic chemobrain
theracurmin
elderly
cognitive impairment
cancer
Geriatrics
RC952-954.6
spellingShingle chemobrain
theracurmin
elderly
cognitive impairment
cancer
Geriatrics
RC952-954.6
Erken N
Dost Gunay FS
Soysal P
Isik AT
The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
description Neziha Erken,1 Fatma Sena Dost Gunay,1 Pinar Soysal,2 Ahmet Turan Isik1 1Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; 2Department of Geriatric Medicine, Bezmialem Vakif University, Faculty of Medicine, Istanbul, TurkeyCorrespondence: Ahmet Turan IsikUnit for Brain Aging and Dementia, Department of Geriatric Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey Tel +90 232 412 43 41Fax +90 232 412 43 49Email atisik@yahoo.comAbstract: Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.Keywords: chemobrain, Theracurmin, elderly, cognitive impairment, cancer
format article
author Erken N
Dost Gunay FS
Soysal P
Isik AT
author_facet Erken N
Dost Gunay FS
Soysal P
Isik AT
author_sort Erken N
title The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
title_short The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
title_full The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
title_fullStr The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
title_full_unstemmed The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain
title_sort effect of theracurmin on cognitive function in an older patient with chemobrain
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/7a561dbbf3874fcdae405a541aac8ffa
work_keys_str_mv AT erkenn theeffectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT dostgunayfs theeffectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT soysalp theeffectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT isikat theeffectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT erkenn effectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT dostgunayfs effectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT soysalp effectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
AT isikat effectoftheracurminoncognitivefunctioninanolderpatientwithchemobrain
_version_ 1718398370891956224